Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Colorcon
Mallinckrodt
Boehringer Ingelheim
McKinsey
Merck
Express Scripts

Last Updated: November 17, 2019

DrugPatentWatch Database Preview

Details for Patent: 10,098,866

See Plans and Pricing

« Back to Dashboard

Which drugs does patent 10,098,866 protect, and when does it expire?

Patent 10,098,866 protects ROZEREM and is included in one NDA.

This patent has twelve patent family members in seven countries.

Summary for Patent: 10,098,866
Title:Pharmaceutical preparation containing copolyvidone
Abstract: A stabilized preparation which comprises: a unstable drug in a polyethylene glycol-containing preparation; and a coating agent comprising a copolyvidone instead of polyethylene glycol with which the drug is coated.
Inventor(s): Ishida; Hajime (Osaka, JP), Fukuta; Makoto (Nara, JP)
Assignee: Takeda Pharmaceutical Company Limited (Osaka, JP)
Application Number:15/234,604
Patent Claim Types:
see list of patent claims
 

Drugs Protected by US Patent 10,098,866

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Takeda Pharms Usa ROZEREM ramelteon TABLET;ORAL 021782-001 Jul 22, 2005 AB RX Yes Yes   Start Trial   Start Trial Y METHOD OF TREATING A BIOLOGICAL RHYTHM DISORDER, SUCH AS INSOMNIA   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 10,098,866

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan2000-351223Nov 17, 2000

International Family Members for US Patent 10,098,866

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 469644   Start Trial
Australia 1430502   Start Trial
Canada 2428817   Start Trial
Canada 2650698   Start Trial
Germany 60142305   Start Trial
European Patent Office 1334732   Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Boehringer Ingelheim
McKinsey
Johnson and Johnson
Merck
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.